Nexocin Ec (Naproxen)

Naproxen, the active ingredient in Nexocin Ec, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It relieves mild to moderate pain, inflammation, arthritis and dysmenorrhea in adults.

GNH USA supplies Nexocin Ec as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen is an NSAID that reduces inflammation and pain by inhibiting prostaglandin synthesis.

- Mild to moderate pain: provides analgesic relief for conditions such as headache, toothache, and musculoskeletal discomfort. - Inflammation: decreases swelling associated with conditions like tendonitis and bursitis. - Arthritis: alleviates joint pain and stiffness in osteoarthritis and rheumatoid arthritis. - Dysmenorrhea: reduces menstrual cramps and associated discomfort.

Naproxen may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness: transient sensation of lightheadedness. - Rash: mild skin irritation or itching.

Serious or Rare Side Effects: - Gastrointestinal bleeding: ulceration or hemorrhage in the stomach or intestines. - Cardiovascular events: increased risk of heart attack or stroke, especially with long‑term use. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

When prescribing or dispensing naproxen, consider the following precautions to minimize risk.

- Renal function: assess kidney health before use, especially in patients with chronic renal disease. - Cardiovascular risk: avoid in individuals with a history of heart disease or uncontrolled hypertension. - Gastrointestinal history: use cautiously in patients with prior ulcers or gastrointestinal bleeding. - Concomitant anticoagulants: monitor for enhanced bleeding risk when combined with warfarin or antiplatelet agents. - Pregnancy and lactation: avoid during the third trimester and discuss risks with a healthcare provider if breastfeeding. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture and direct sunlight.

Naproxen can interact with several medicines; awareness of major and moderate interactions helps ensure safe therapy.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may increase bleeding risk. - Selective COX‑2 inhibitors (e.g., celecoxib): additive gastrointestinal toxicity. - Lithium: naproxen can raise lithium serum concentrations.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function; monitor creatinine. - Diuretics: potential for reduced efficacy and renal impairment. - Methotrexate: may increase methotrexate toxicity; monitor levels.